C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to obtain a Drug Establishment License (DEL) to produce life-saving cell therapies ...
C3i obtained a Drug Establishment License (DEL) to produce cell therapies for patients across Canada commercially.
In a report released today, Peter Lawson from Barclays maintained a Hold rating on Blueprint Medicines (BPMC – Research Report), with a price target of $105.00. The company’s shares closed ...
European leaders sought to form a united front Monday at emergency talks in Paris, called after a U.S. diplomatic blitz on Ukraine which has thrown a once-solid alliance into turmoil and left the ...
European leaders have been stunned by a weeklong diplomatic blitz on Ukraine from the Trump administration that seemed to embrace the Kremlin while it cold-shouldered many of its age-old European ...
leaving the impression that Washington was ready to embrace the Kremlin while it cold-shouldered many of its age-old European allies. Despite belligerent warnings for months ahead of Donald Trump ...
leaving the impression that Washington was ready to embrace the Kremlin while it cold-shouldered many of its age-old European allies. Despite belligerent warnings for months ahead of Donald Trump ...
Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® ...
European peace mission may weaken NATO's own defences, need U.S. support Experts doubt Europe's ability to raise combat-ready troops fast Russia opposes NATO troops in Ukraine, questions ...
The American president’s latest remarks embracing Vladimir Putin’s narrative that Ukraine is to blame for the war have compounded the sense of alarm among traditional allies. By Catherine ...
Since last week, senior US officials on their first visit to Europe have left the impression that Washington is ready to embrace the Kremlin while it cold-shoulders many of its age-old European ...